BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Janssen-Cilag AG 

Sihlbruggstrasse 111

Baar    6340  Switzerland
Phone: 41-41-7673434 Fax: 41-41-7673400


SEARCH JOBS




Industry
Biotechnology


Collaborations

Alkermes plc 





 Company News
National Institute for Clinical Excellence (NICE) Rejects Early Use Of Janssen-Cilag AG's Velcade For Multiple Myeloma 11/12/2013 7:35:59 AM    More...
Janssen-Cilag AG Release: ZYTIGA® Approved in the EU for Use in the Treatment of Metastatic Castration-Resistant Prostate Cancer Before Chemotherapy 1/11/2013 10:00:52 AM    More...
Janssen-Cilag AG Acquires CorImmun 6/28/2012 10:31:03 AM    More...
Basilea Pharmaceutica (BSLN.SW) Announces Discontinuation of Sale of Ceftobiprole by Janssen-Cilag AG, a Johnson & Johnson (JNJ) Company, In Switzerland 9/9/2010 7:03:45 AM    More...
Janssen-Cilag AG Submits Marketing Authorisation Application in Europe for Paliperidone Palmitate for the Treatment of Schizophrenia 12/4/2009 10:14:44 AM    More...
Janssen-Cilag AG Announces CHMP Delays European Commission Decision Process to Approve ZEVTERATM 2/24/2009 7:58:43 AM    More...
PPD, Inc. (PPDI) to Receive Milestone Payments for First Regulatory Approvals of Priligy(TM) (Dapoxetine) in Finland and Sweden for Treatment of Premature Ejaculation 2/10/2009 10:07:18 AM    More...
Janssen-Cilag AG's Priligy(TM) (Dapoxetine) Receives First Regulatory Approvals for the Treatment of Premature Ejaculation (PE) in Finland and Sweden 2/10/2009 6:59:29 AM    More...
Janssen-Cilag AG New Biologic STELARA(TM) Receives Approval in Europe for Treatment of Moderate to Severe Plaque Psoriasis 1/22/2009 10:42:20 AM    More...
Janssen-Cilag AG's New Antibiotic Against Serious Infections - Receives First Approval in Europe 11/13/2008 7:26:08 AM    More...
12